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Introduction
Linear regression models are often used to explore the relation between a continuous outcome and independent variables; note that binary outcomes may also be used [1, 2] . To fulfil "the" normality assumption researchers frequently perform arbitrary outcome transformation. For example, using information on more than 100,000 subjects Tyrrel et al 2016 [3] explored the relation between height and deprivation using a rank-based inverse normal transformation, or Eppinga et al 2017 [4] who explored the effect of metformin on the square root of 233 metabolites.
In this paper we argue that outcome transformations change the target estimate and hence bias results. Second, the relevance of the normality assumption is challenged, namely, that nonnormally distributed residuals do not impact bias, nor do they (markedly) impact tests in large sample sizes. Instead of focussing on the normality assumption, more consideration should be given to the detection of 1) trends between the residuals and the independent variables, 2) multivariable outlying outcome or predictor values, and 3) general errors in the parametric model. Unlike violations of the normality assumption these issues impact results irrespective of sample size. As an illustrative example the association between years since type 2 diabetes mellitus (T2DM) diagnosis and HbA1c (outcome) is considered [5] .
Bias due to outcome transformations
First, let us define a linear model and which part of the model the normality assumption pertains to:
Here is the continuous outcome variable (e.g., HbA1c) an independent variable (e.g., years since T2DM diagnosis), parameter 0 the ̅ value when = 0 (e.g., the intercept term representing the average HbA1c at time of diagnosis), and the errors which are the only part assumed to follow a normal distribution. Often one is interested in estimating 1 (e.g., the slope) as an outcome. For example, the acidity of a solution is typically indicated by the pH (potential of hydrogen) which is best understood on the logarithmic scale. Similarly, this type of bias is only relevant in so far one is interested in interpreting ̂1 , if for example one is concerned with prognostication, outcome transformations are less of an issue. Furthermore, hypothesis tests from linear regression models using arbitrary transformed outcomes are still valid. However, as stated before, in using linear regression models we assume researchers are interesting in estimating the magnitude of an association. If, instead, a researcher is interested in testing a (null-) hypothesis non-parametric methods will often be more appropriate.
The normality assumption in large sample size settings
We define large sample size as a setting where the observations are larger than the number of parameters one is interested in estimating. As a pragmatic indication we use > 10, but realize that this may likely differ from application to application.
To discuss the relevance of the normality assumption we look to the Gauss-Markov theorem [6] , which states that the ideal linear regression estimates are both unbiased and have the least amount of variance, a property called the "best linear unbiased estimators" (BLUE). Linear regression estimates are BLUE when the errors have mean zero, are uncorrelated and have equal variance across different values of the independent variables (i.e., homoscedasticity) [6] .
The normality assumption is thus not necessary to get estimates with the BLUE property.
However, in small sample size settings (relative to ) the standard error estimates may be biased (and hence confidence intervals and p-values as well) when the errors do not follow a normal distribution. For formal proofs of the BLUE characteristics please see the historically relevant Aitken, 1936 [6] , and chapter 2 of Faraway, 2015 [7] 7
To empirically assess the relevance of the normality assumption we performed an illustrative simulation using 4 scenarios with a single independent variable and an error distribution, following either: 1) the standard normal distribution, 2) a uniform distribution, 3) a beta distribution, 4) a normal distribution where the errors depend on (i.e., heteroscedasticity). Based on these scenarios 3, 10, 100, 1000, 10 000 and 100 000 subjects were sampled (repeated 10 000 times) and the linear model of equation 1 was fitted to the data. Given that in these settings point estimates will be unbiased on average ( ̅ 1 = 1 ), we evaluated performance on the number of times the 95% confidence interval included 1 (i.e., coverage). Figure 2 shows that despite the errors not following a normal distribution, in scenario 2-3 coverage is ~0.95 in larger sample sizes. However, in scenario 4 despite the residuals more closely following a normal distribution coverage in large sample sizes is consistently lower than the nominal 0.95 level. Moreover, as the sample size increased coverage did not improve.
Model diagnostics
As the above illustrates, linear models without normally distributed residuals may nevertheless produce valid results, especially given sufficient sample size. Conversely, the following modelling assumptions are sample size invariant and should be carefully checked regardless of As an example, in the Appendix we have applied the above discussed modelling diagnostics on the HbA1c data. Based on these steps we come to the conclusion that conditional on the covariates, age, marital status, and body mass index (BMI), time since T2DM diagnosis has a non-linear relation with HbA1c; where its level initially increases, only to decrease around 9.5 years after T2DM diagnosis.
Discussion and recommendations
In this brief outline of much larger theoretical works [6, 10] we show that given sufficient sample size, linear regression models without normally distributed errors are valid. Despite this wellknown characteristic, arbitrarily outcome transformations are often applied in an attempt to force the residuals to follow a normal distribution. As discussed such transformation frequently bias slope coefficients (as well as standard errors) and should be discouraged. What constitutes large sample size obviously differs between analyses, before we mentioned a ratio of 10 observations per parameter, however lower values have been found sufficient as well [11] .
Conversely, larger values (e.g., 50) may be necessary when variables are correlated or variable distributions result in localized (multivariate) sparse data settings. As such in no way should this manuscript be misconstrued into arguing that linear regression should always be used, and especially not without critical reflection of modelling assumptions. Instead we simply wish to make the point that the linear model often performs adequately, even when some assumptions are violated. This robust behaviour of linear regression can be extended in many ways, for example generalized least square can be used in the presence of correlated errors, weighted least squares in the presence of heteroscedasticity, or RIDGE and LASSO regression in the presence of sparse data (e.g., ≤ 1). All these methods are in essence still linear models making a thorough understanding of the underlying modelling assumptions, as presented here, crucial.
Ideally, model decisions should be based on prior, topic specific, knowledge. If such external information is absent graphical tests (as presented here) should be used to detect grossly wrong assumption, not to optimize fit, which likely biases results far beyond any assumption violation [12, 13] .
In conclusion, in large sample size settings linear regression models are fairly robust to violations of the normality assumption and hence arbitrary -bias inducing -outcome transformations are usually unnecessary. Instead, researchers should focus on detection of model miss-specifications such as outlying values, high leverage, heteroscedasticity, correlated errors, non-linearity, and interactions which may bias results irrespective of sample size.
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